EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.

about

EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.

Item

http://www.wikidata.org/entity/Q38618544

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

EpCAM Expression in Lymph Node ...... of the Bladder: A Pilot Study.

@en

type

Item

label

EpCAM Expression in Lymph Node ...... of the Bladder: A Pilot Study.

@en

prefLabel

EpCAM Expression in Lymph Node ...... of the Bladder: A Pilot Study.

@en

P1476

EpCAM Expression in Lymph Node ...... of the Bladder: A Pilot Study.

@en

P2093

Christa A M van der Fels

http://www.w3.org/2001/XMLSchema#string

Igle J de Jong

http://www.w3.org/2001/XMLSchema#string

Stefano Rosati

http://www.w3.org/2001/XMLSchema#string

P2860

EpCAM overexpression is associated with high-grade urothelial carcinoma in the renal pelvis.

Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.

A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients.

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.

The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review.

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

P31

scholarly article

P356

10.3390/IJMS18081802

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28820475

http://www.w3.org/2001/XMLSchema#string

P932

5578189

http://www.w3.org/2001/XMLSchema#string